Simplex Trading’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-47,200
| Closed | -$10.4M | – | 9141 |
|
|
2025
Q4 | $10.4M | Buy |
47,200
+27,000
| +134% | +$4.36M | 0.01% | 824 |
|
|
2025
Q3 | $1.93M | Sell |
20,200
-32,300
| -62% | -$2.06M | ﹤0.01% | 2360 |
|
|
2025
Q2 | $2.56M | Buy |
52,500
+50,700
| +2,817% | +$1.22M | ﹤0.01% | 1890 |
|
|
2025
Q1 | $38K | Buy |
+1,800
| New | +$40K | ﹤0.01% | 6041 |
|
|
2023
Q4 | – | Sell |
-975
| Closed | -$18K | – | 8859 |
|
|
2023
Q3 | $18K | Buy |
975
+90
| +10% | +$1.77K | ﹤0.01% | 6697 |
|
|
2023
Q2 | $20K | Buy |
885
+460
| +108% | +$10.8K | ﹤0.01% | 6762 |
|
|
2023
Q1 | $10K | Buy |
+425
| New | +$12.1K | ﹤0.01% | 7527 |
|
|
2022
Q2 | – | Sell |
-175
| Closed | -$2K | – | 10036 |
|
|
2022
Q1 | $2K | Buy |
+175
| New | +$2.97K | ﹤0.01% | 9826 |
|
|
2021
Q4 | – | Sell |
-30
| Closed | -$1K | – | 10526 |
|
|
2021
Q3 | $1K | Hold |
30
| – | – | ﹤0.01% | 9623 |
|
|
2021
Q2 | $1K | Buy |
30
+29
| +2,900% | +$1.23K | ﹤0.01% | 9800 |
|
|
2021
Q1 | $4K | Buy |
+1
| New | +$49 | ﹤0.01% | 8250 |
|
|
2020
Q4 | – | Sell |
-2
| Closed | -$12K | – | 8379 |
|
|
2020
Q3 | $12K | Sell |
2
-9
| -82% | -$636 | ﹤0.01% | 6690 |
|
|
2020
Q2 | $77K | Buy |
11
+8
| +267% | +$518 | ﹤0.01% | 5075 |
|
|
2020
Q1 | $15K | Buy |
3
+1
| +50% | +$60 | ﹤0.01% | 6164 |
|
|
2019
Q4 | $18K | Buy |
+2
| New | +$92 | ﹤0.01% | 6013 |
|
|
2018
Q4 | – | Sell |
-2
| Closed | -$14K | – | 7053 |
|
|
2018
Q3 | $14K | Buy |
+2
| New | +$176 | ﹤0.01% | 6215 |
|
Simplex Trading's CDTX Position: Q1 2026 in Review
Simplex Trading sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 5,230 shares — an estimated $1.16M sold.
Simplex Trading first reported a position in CDTX in Q1 2018 and held it in 11 quarters. The position peaked at $3.31M in Q2 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.
- Simplex Trading reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 5,230 Cidara Therapeutics shares in Q1 2026, an estimated $1.16M.
- Simplex Trading first reported a position in Cidara Therapeutics in Q1 2018 and held it in 11 quarters.
- Simplex Trading's Cidara Therapeutics position peaked at $3.31M in Q2 2025.
- 0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.